Request Deal Involvement

HBM Healthcare led a €127m Series B funding round in IO Biotech.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Cook Williams Communications

pr advisors

Cook Williams Communications

or

Principals

IO BIOTECH

target

IO BIOTECH

LUNDBECKFONDEN EMERGE

bidder

LUNDBECKFONDEN EMERGE

VIVO CAPITAL LLC

bidder

VIVO CAPITAL LLC

KURMA PARTNERS

bidder

KURMA PARTNERS

NOVO SEEDS

bidder

NOVO SEEDS

HBM HEALTHCARE INVESTMENTS

bidder

HBM HEALTHCARE INVESTMENTS

AVORO CAPITAL

bidder

AVORO CAPITAL

SOLEUS CAPITAL

bidder

SOLEUS CAPITAL

RA CAPITAL MANAGEMENT

bidder

RA CAPITAL MANAGEMENT

SAMSARA BIOCAPITAL

bidder

SAMSARA BIOCAPITAL

IDINVEST PARTNERS

bidder

IDINVEST PARTNERS

PFM HEALTH SCIENCES

bidder

PFM HEALTH SCIENCES

EIR VENTURES

bidder

EIR VENTURES

SERRADO CAPITAL

bidder

SERRADO CAPITAL

SUNSTONE LIFE SCIENCE VENTURES

bidder

SUNSTONE LIFE SCIENCE VENTURES

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - HBM Healthcare led a €127m Series B funding round in IO Biotech.